Use: Labeled indications
- INDICATIONS AND USAGE LACTULOSE For Oral Solution is indicated for the treatment of constipation.
Full indications and usage US FDA label
INDICATIONS AND USAGE LACTULOSE For Oral Solution is indicated for the treatment of constipation. In patients with a history of chronic constipation, lactulose therapy increases the number of bowel movements per day and the number of days on which bowel movements occur.
Contraindications
CONTRAINDICATIONS Since LACTULOSE For Oral Solution contains galactose (less than 0.3 g/10 g as a total sum with lactose), it is contraindicated in patients who require a low galactose diet.
US FDA labelDosing: Adult
Dosage and administration (US label) US FDA label
DOSAGE AND ADMINISTRATION The usual adult dosage is 10 g to 20 g of lactulose daily. The dose may be increased to 40 g daily if necessary. Twenty-four to 48 hours may be required to produce a normal bowel movement. DIRECTIONS FOR PREPARATION Dissolve contents of packet in half a glass (4 ounces) of water. When Lactulose For Oral Solution is dissolved in water, the resulting solution may be colorless to a slightly pale yellow color.
Dosing: Altered kidney function
No kidney-specific text is available from the US label for this generic yet. Check the Philippine package insert in the products table.
Kidney-specific guidance from renalcarematters.com: in preparation.
Dosing: Pediatric
Pediatric use (US label) US FDA label
Pediatric Use Safety and effectiveness in pediatric patients have not been established.
Dosage forms
Philippines
- Oral solution: 3.33 g per 5 mL, 3.33 g/5 mL, 3.35 g/5 mL, 10 g/15 mL
- Syrup: 3.3 g per 5 mL, 3.3 g/5 mL, 3.33 g/5 mL, 3.35 g/5 mL, 3.35 mg/5 mL
- ) oral solution: 3.3 g/5 mL (10 g/15 mL, 3.33 g/5 mL (10 g/15 mL, 10 g/15 mL (3.33 g/5 mL, 670 mg/mL (3.35 g/5 mL
Registered products in the Philippines
66 products registered with the Food and Drug Administration (FDA) Philippines list Lactulose as the generic name. Registration status changes; confirm a product's current status on the FDA portal before relying on it.
All registered products66
| Package insert | |||||||
|---|---|---|---|---|---|---|---|
AccellacLactulose | 3.35g /5mL SyrupPET Bottle with Pilfer Proof Cap x 60 mL and 120 mL (Box of 1's) | Rx | Opal Laboratories (Pvt.) LimitedPakistan | Accesspoint International Trading Inc. | DRP-4815 | Feb 10, 2032 | |
ActilaxLactulose | 670 mg/mL (3.35 g/5 mL) Oral SolutionOpaque White PET Bottle x 100 mL (Box of 1's) | Rx | Zee LaboratoriesIndia | Importer: Eon Pharmatek Inc. | DR-XY47613 | Dec 17, 2031 | |
AdocLactLactulose | 10 g/15 mL (3.33 g/5 mL) Oral SolutionAmber-colored PET Bottle sealed with 25 mm PP cap x 100 mL (Box of 1's) | Rx | Rhydburg Pharmaceuticals LimitedIndia | Genedrift Philippines OPC | DRP-16033 | Oct 18, 2029 | |
AelacLactulose | 3.35 g/5 ml Oral SolutionAmber PET Bottle with ROPP cap x 100 ml + Measuring cup (Box of 1's) | Rx | PANACEA BIOTEC PHARMA LIMITEDIndia | DYNASTY PHARMACEUTICALSImporter: Medinova Pharmaceutical Inc. | DRP-12458-01 | Aug 12, 2027 | |
AlvolaxusLactulose | 3.3 g/5 mL (10 g/15 mL) Oral SolutionPET/Alu/PE Sachet foil x 15 mL (Box of 20's) | Rx | Fresenius Kabi Austria GmbHAustria | METRO DRUG, INC.Trader: Alvogen Asia Pacific Holdings Limited | DR-XY45868 | May 31, 2027 | |
AvolacLactulose | 3.35 g/5 mL Oral SolutionWhite PVDC Plastic Bottle x 100 mL and 200 mL | Rx | Aristopharma Ltd.Bangladesh | Sahar International Trading Inc. | DR-XY42042 | May 24, 2028 | |
B-LactLactulose | 3.35 g/5 mL SyrupAmber Glass Bottle x 120 mL with Measuring Cup (Box of 1's) | Rx | Fresenius Kabi Austria GmbHAustria | Sahar International Trading, Inc.Importer: Sahar International Trading Inc.Trader: Brookes Pharma (Private) Limited | DRP-5264 | Apr 5, 2028 | |
BIOLACLactulose | 3.33 g/5 mL Oral SolutionAmber PET Bottle x 120 mL (Box of 1's) | Rx | UNITED BIOTECH PVT. LTD.India | TRIPLE TACT IMPORT & EXPORT CORP. | DRP-7545 | Oct 3, 2028 | |
ConsiloseLactulose | 3.33 g per 5 mL Oral SolutionAmber Colored PET Bottle x 120 mL (Box of 1's) | Rx | Scott-Edil Pharmacia LimitedIndia | Teramedix Pharma Trading Inc.Importer: Pharmakon Biotec Inc. | DRP-5413-01 | Aug 4, 2029 | |
ConstilaxLactulose | 10 g/15 mL (3.33 g/5 mL) Oral SolutionAmber PET bottle x 120 mL with ROPP cap + 15 mL PP measuring cup (Box of 1's) | Rx | Wallace Pharmaceuticals Pvt. Ltd.India | Hexagon Pharmaceuticals | DRP-16032 | Oct 18, 2029 | |
DixiloseLactulose | 3.33 g/5 mL Oral Solution | Rx | Magbro Healthcare Pvt. Ltd.India | Teramedix Pharma Trading Inc.Importer: Pharmakon Biotec Inc. | DRP-9124-06 | Sep 4, 2030 | |
DolacLactulose | 10 g/15 mL (3.33 g/5 mL) Oral Solution120 mL and 200 mL Polyethylene Bottle [Box of 1's] | Rx | Rhydburg Pharmaceuticals LimitedIndia | Genedrift Philippines OPC | DRP-13533 | Mar 8, 2028 | |
DuphalacLactulose | 3.3 g/ 5 mL SyrupAmber bottle 45mL and 120mL | OTC | Abbott Healthcare Products B.V.Netherlands | Zuellig Pharma CorporationTrader: Abbott Laboratories | DRP-222 | Mar 31, 2027 | |
Duphalac MomLactulose | 3.3g/5mL Syrup (Plum-flavored)White Opaque HDPE Blow-mould Bottle with Tamper-evident White Opaque PP Screw Cap and Translucent PP Measuring Cup x 200mL (Box of 1's) | OTC | Abbott Biologicals B.V.Netherlands | Importer: Abbott Laboratories | DR-XY46203 | Dec 28, 2027 | |
DylacLactulose | 3.33 g/5 mL Oral SolutionAmber PET Bottle with 10 mL Plastic Measuring Cup x 120 mL (Box of 1's) | Rx | Magbro Healthcare Pvt. LtdIndia | Dynasty PharmaceuticalsImporter: Pharmakon Biotec Inc | DRP-9124-11 | Sep 4, 2030 | |
EasylacLactulose | 3.35 g/5 mL Oral SolutionAmber PET Bottle With ROPP cap x 100 mL + measuring cup (Box of 1’s) | Rx | Panacea Biotec Ltd.India | Medinova Pharmaceutical Inc. | DRP-12458 | Aug 12, 2027 | |
EasyloozLactulose | 3.33 g/5 mL SyrupAmber-colored PET bottle sealed with 25 mm PP cap with 10 mL measuring cup x 120 mL (Box of 1's) | Rx | Stallion Laboratories Pvt. Ltd.India | Danzz Pharma Marketing Inc.Importer: Ambica International Corporation | DRP-9183-02 | Sep 30, 2030 | |
GeolacLactulose | 3.35 g/5 mL SyrupPET Bottle with Pilfer Proof Cap x 60 mL and 120 mL (Box of 1's) | Rx | Opal Laboratories (Pvt.) Ltd.Pakistan | Geo Pak International Trading Corp.Importer: Accesspoint International Trading Inc | DRP-4815-02 | Feb 10, 2027 | |
GolactuloseLactulose | 3.33 g/5 mL Oral Solution | Rx | Magbro Healthcare Pvt. Ltd.India | Applied Pharmaceutical Distribution Inc.Importer: Pharmakon Biotec Inc | DRP-9124-12 | Sep 4, 2030 | |
HailacLactulose | 3.33 g/5 mL Oral SolutionAmber PET Bottle x 120 mL (Box of 1's) | Rx | UNITED BIOTECH PVT. LTD.India | GREENCORE PHARMA INC.Importer: TRIPLE TACT IMPORT & EXPORT CORP. | DRP-7545-01 | Oct 3, 2028 | |
KleenlacLactulose | 3.35 g/5 mL Syrup.60 mL and 120 mL Amber Glass Bottle (Box of 1's) | Rx | Nabiqasim Industries (Pvt.) Ltd.Pakistan | Accesspoint International Trading, Inc. | DRP-14641 | Nov 9, 2028 | |
Laclose ProLactulose | 3.33g / 5mL Oral SolutionAmber PET Bottle with 10 mL Plastic Measuring Cup x 120 mL (Box of 1's) | Rx | Magbro Healthcare Pvt. Ltd.India | Teramedix Pharma Trading Inc.Importer: Pharmakon Biotec Inc. | DRP-9124-15 | Sep 4, 2030 | |
LACTOBURGLactulose | 3.33 g/5 mL Oral SolutionPET amber plastic bottle x 120 mL in a monocarton and 200 mL in a monocarton (Box of 1's) | Rx | Rhydburg Pharmaceuticals Ltd.India | Sanimed Pharmaceuticals Inc. | DRP-10806 | Nov 25, 2031 | |
LactokhrizLactulose | 3.33 g/5 mL Oral SolutionPET Amber plastic bottle x 60 mL, 120 mL, and 200 mL (Box of 1's) | Rx | Rhydburg Pharmaceuticals Ltd.India | Khriz Pharma Trading, Inc. | DRP-10807 | Nov 25, 2031 | |
LactopenLactulose | 3.33 g/5 mL Oral SolutionPET amber plastic bottle x 60mL, 120 mL and 200 mL (Box of 1's) | Rx | Rhydburg Pharmaceuticals Ltd.India | A. Pendragon International Distribution OpcImporter: Khriz Pharma Trading, Inc. | DRP-10807-01 | Nov 25, 2026 | |
LactosanLactulose | 3.33 g/ 5 mL Oral SolutionPET amber plastic bottle x 120 mL in a monocarton and 200 mL in a monocarton (Box of 1's) | Rx | Rhydburg Pharmaceuticals Ltd.India | Hillcross Prime, Inc.Importer: Sanimed Pharmaceuticals Inc. | DRP-10806-01 | Nov 25, 2026 | |
LactowynLactulose | 10g/15mL Oral Solution120 mL amber colored PET bottle with silver cap + 10 mL measuring cap (Box of 1's) | Rx | Magbro Healthcare Pvt. Ltd.India | Teramedix Pharma Trading Inc. | DR-XY47799 | Mar 10, 2027 | |
LactucareLactulose | 3.35g/5 mL SyrupPET Bottle with Pilfer Proof Cap x 120 mL (Box of 1's) | Rx | Opal Laboratories (Pvt.) LimitedPakistan | Euro-Care Products PhilippinesImporter: Accesspoint International Trading Inc. | DRP-4815-06 | Feb 10, 2027 | |
LactudenLactulose | 3.33 g/5 mL Oral Solution | Rx | Magbro Healthcare Pvt. Ltd.India | Cyden Medicale Trading Inc.Importer: Pharmakon Biotec Inc. | DRP-9124-10 | Sep 4, 2030 | |
LactueaseLactulose | 3.33 g / 5mL Oral SolutionAmber PET Bottle with 10 mL Plastic Measuring Cup x 120 mL (Box of 1's) | Rx | Magbro Healthcare Pvt. Ltd.India | Vitalife Pharma & Medical Supply Inc.Importer: Pharmakon Biotec Inc. | DRP-9124-16 | Sep 4, 2030 | |
LactulLactulose | 3.35g/5mL Oral Solution100 mL PET Plastic Amber Colored Bottle | Rx | Y.S.P. Industries (M) Sdn. Bhd.Malaysia | Yung Shin (Philippines), Inc. | DR-XY32453 | Oct 18, 2031 | |
LactulifeLactulose | 3.35 g/5 mL Syrup30 Ml, 45 Ml, 60 Ml, And 120 Ml Pet Round Amber Bottle With white ROPP Aluminum Cap (Box of 1's) | Rx | Nucare Labs LLPIndia | Biophil Medical Equipment and Supplies Trading | DRP-18548 | Jul 29, 2031 | |
LactunavLactulose | 3.33 g / 5mL Oral SolutionAmber PET Bottle with 10 mL Plastic Measuring Cup x 120 mL (Box of 1's) | Rx | Magbro Healthcare Pvt. Ltd.India | JNC Pharmaceuticals CorporationImporter: Pharmakon Biotec Inc. | DRP-9124-14 | Sep 4, 2030 | |
LactusaphLactulose | 3.33 g/5 mL Syrup20 mL-capacity USP Type I Clear Colorless Glass Vial with Bromobutyl Rubber Stopper and Aluminum Flip-off Seal (Box of 1's) | Rx | Enicar Pharmaceuticals Pvt. Ltd.India | Nelpa Lifesciences, Inc.Trader: Sapphire Lifesciences Pvt. Ltd. | DRP-13607 | Mar 17, 2028 | |
LactusaphLactulose | 3.35 mg/5 mL Syrup30 mL, 45 mL, 60 mL and 120 mL PET Round Amber Bottle | Rx | Azine Healthcare Pvt. Ltd.India | Ollen Pharma Trading Inc.Trader: Sapphire Lifesciences Pvt. Ltd. | DRP-11001 | Dec 31, 2026 | |
LactuSaveLactulose | 3.35 g / 5 mL SyrupPET Bottle with Pilfer Proof Cap x 60 ml and 120ml (Box of 1's) | Rx | Opal Laboratories (Pvt.) LimitedPakistan | Savelink Pharma and Trading Co.Importer: Accesspoint International Trading Inc. | DRP-4815-09 | Feb 10, 2027 | |
LactusolLactulose | 3.35g/5mL Oral Solution120 mL PET amber bottle with HDPE screw cap (Box of 1’s) | Rx | KCK Pharmaceutical Industries Sdn. Bhd.Malaysia | Endure Medical, Inc. | DR-XY48279 | Aug 12, 2027 | |
LaxedilLactulose | 3.33 g per 5 mL Oral SolutionAmber colored PET Bottle x 120 mL (Box of 1's) | Rx | Scott-Edil Pharmacia LimitedIndia | Cyden Medicale Trading Inc.Importer: Pharmakon Biotec Inc. | DRP-5413 | Aug 4, 2029 | |
LaxfreeLactulose | 3.3 g per 5 mL SyrupAmber Coloured PET Bottle x 120 mL (Box of 1's) | Rx | Stallion Laboratories Pvt. Ltd.India | Orange Biotec Inc.Trader: Mac Heal Laboratories Ltd. | DRP-9547 | Apr 15, 2029 | |
LaxigenLactulose | 10g/15 mL (3.33 g/5 mL) Oral Solution120 mL and 200 mL Polyethylene Bottle [Box of 1's] | Rx | Rhydburg Pharmaceuticals LimitedIndia | Tazio Lifescience Inc.Importer: Pharmastar Int'l Trading Corp. | DRP-13533-02 | Mar 8, 2028 | |
LaxipateLactulose | 3.33 g/5 mL SyrupAmber-colored PET bottle sealed with 25 mm PP cap with 10 mL measuring cup x 120 mL (Box of 1's) | Rx | Stallion Laboratories Pvt. Ltd.India | The Cathay Drug Co., Inc.Importer: Ambica International Corporation | DRP-9183-03 | Sep 30, 2030 | |
LaxipateLactulose | 3.35 g/ 5 mL Syrup (Caramel Flavor)PET round amber bottle with white aluminum cap and measuring cup x 120 mL (Box of 1's) | Rx | Azine Healthcare Pvt. Ltd.India | The Cathay Drug Co., Inc.Importer: Ollen Pharma Trading Inc.Trader: Sapphire Lifesciences Pvt. Ltd. | DRP-11001-01 | Dec 31, 2026 | |
LaxitolLactulose | 10 g/15 mL (3.33g/5mL) Oral Solution120 mL and 200 mL Polyethylene Bottle (Box of 1's) | Rx | Rhydburg Pharmaceuticals LimitedIndia | Healthwinds Medical Trading CorpImporter: Pharmastar Int'l Trading Corp. | DRP-13533-01 | Mar 8, 2028 | |
LaxolLactulose | 3.33 g/5 mL (10 g/15 mL) Oral Solution120 mL PET Bottle (Box of 1's) | Rx | Rhydburg Pharmaceuticals LimitedIndia | Endure Medical, Inc. | DRP-XY49432 | Jun 30, 2030 | |
LaxoseLactulose | 3.35 g/5 mL SyrupAmber Glass Bottle with measuring cup x 100mL (Box of 1's) | Rx | Biopharma Laboratories LimitedBangladesh | JF Draf Pharmaceuticals Corporation | DRP-6207 | Jun 29, 2030 | |
LilacLactulose | 3.35 g/5 mL SyrupAmber-colored PET Bottle of 60 mL and 120 mL (Box of 1's) | Rx | Opal Laboratories (Pvt.) Limited.Pakistan | Getz Pharma (Phils.), Inc.Trader: Getz Pharma (Pvt.) Ltd. | DR-XY41630 | Jul 21, 2030 | |
LivalacLactulose | 3.3g/5mL SyrupType II Amber Glass Bottle Sealed with White Aluminum Cap x 100mL (Box of 1's) | Rx | Olic (Thailand) LimitedThailand | Paradigm Pharma (Philippines) Corporation | DRP-16637 | May 23, 2030 | |
MegalaxLactulose | 3.33 g per 5 mL Oral SolutionAmber Colored PET Bottle x 120 mL (Box of 1's) | Rx | Scott-Edil Pharmacia LimitedIndia | Meganorth PharmaImporter: Pharmakon Biotec Inc. | DRP-5413-04 | Aug 4, 2029 | |
MovelaxLactulose (as Lactulose Concentrate) | 3.3 g/5 mL SyrupAmber Glass Bottle with Aluminum Pilfer-Proof x 120 mL and 30 mL (Box of 1's) | Rx | Amherst Laboratories, Inc.Philippines | Trader: UNILAB, INC. | DR-XY37503 | Apr 12, 2031 | |
NoneLactulose | 3.33 g/5 mL Oral SolutionAmber PET Bottle x 120 mL (Box of 1's) | Rx | UNITED BIOTECH PVT. LTD.India | TGP PHARMA INC.Importer: TRIPLE TACT IMPORT & EXPORT CORP. | DRP-7545-02 | Oct 3, 2028 | |
NoneLactulose | 3.35 g/5 mL Oral SolutionAmber PET Bottle x 120 mL with HDPE screw cap and medicine cup (Box of 1's) | OTC | KCK Pharmaceutical Industries Sdn. Bhd.Malaysia | TGP Pharma Inc.Importer: GreenCore Pharma Inc. | DRP-13301-01 | Jan 20, 2028 | |
NoneLactulose | 3.35g / 5mL SyrupPET Bottle with Pilfer Proof Cap x 60 mL and 120 mL (Box of 1's) | Rx | Opal Laboratories (Pvt.) LimitedPakistan | Reta DrugImporter: Accesspoint International Trading Inc. | DRP-4815-08 | Feb 10, 2027 | |
One-LactLactulose | 3.35g/5 mL SyrupPET Bottle with Pilfer Proof Cap x 60 mL and 120 mL (Box of 1's) | Rx | Opal Laboratories (Pvt) LtdPakistan | One-Dexcel Pharma Inc.Importer: Accesspoint International Trading, Inc. | DRP-4815-03 | Feb 10, 2027 | |
PeptoburgLactulose | 3.33 g/5 mL Oral SolutionPET amber plastic bottle x 120 mL and 200 mL (as net content). | Rx | Rhydburg Pharmaceuticals Ltd.India | Khriz Pharma Trading, Inc. | DRP-10805 | Nov 25, 2026 | |
PilltuloseLactulose | 3.33 g / 5 mL SyrupAmber-colored PET bottle sealed with 25 mm PP cap with 10 mL measuring cap x 120 mL (Box of 1's) | Rx | Stallion Laboratories Pvt. Ltd.India | AGB Pharmaceutical Trading and Consultancy CorporationImporter: Ambica International Corporation | DRP-9183-04 | Sep 30, 2030 | |
ProlacLactulose | 3.33 g / 5mL Oral SolutionAmber PET Bottle with 10 mL Plastic Measuring Cup x 120 mL (Box of 1's) | Rx | Magbro Healthcare Pvt. Ltd.India | Pro Medica Inc.Importer: Pharmakon Biotec Inc. | DRP-9124-13 | Sep 4, 2030 | |
RetalacLactulose | 3.35 g/5mL Oral SolutionAmber PET Bottle With ROPP cap x 100 mL + Measuring Cup (Box of 1's) | Rx | Panacea Biotec Pharma LimitedIndia | Reta DrugImporter: Medinova Pharmaceutical Inc. | DRP-12458-02 | Aug 12, 2027 | |
RexulacLactulose | 3.35 g/ 5mL SyrupPET Bottle with Pilfer Proof Cap x 60 mL and 120 mL (Box of 1's) | Rx | Opal Laboratories (Pvt.) LimitedPakistan | Rexmed Pharmaceutical SalesImporter: Accesspoint International Trading Inc. | DRP-4815-07 | Feb 10, 2027 | |
RifelacLactulose | 3.33 g/5 mL SyrupAmber-colored PET bottle sealed with 25 mm PP cap with 10 mL measuring cup x 120 mL (Box of 1's) | Rx | Stallion Laboratories Pvt. Ltd.India | Rifemedica CorporationImporter: Ambica International Corporation | DRP-9183-01 | Sep 30, 2030 | |
SeticonLactulose | 3.35g/5 mL SyrupPET Bottle with Pilfer Proof Cap x 60 mL and 120 mL (Box of 1's) | Rx | Opal Laboratories (Pvt.) LimitedPakistan | Eliset Pharmaceutical, Inc.Importer: Accesspoint International Trading Inc. | DRP-4815-05 | Feb 10, 2027 | |
SialaxLactulose | 3.35 g/5 mL SyrupPET Bottle with Pilfer Proof Cap x 120 mL (Box of 1's) | Rx | Opal Laboratories (Pvt.) LimitedPakistan | Asianmeds, Inc.Importer: Accesspoint International Trading, Inc. | DRP-4815-10 | Feb 10, 2027 | |
Stal-lactLactulose | 3.33 g/5 mL SyrupAmber-colored PET bottle sealed with 25 mm PP cap with 10 mL measuring cap x 60 mL and 120 mL (Box of 1's) | Rx | Stallion Laboratories Pvt. Ltd.India | Ambica International Corporation | DRP-9183 | Sep 30, 2030 | |
UnilacLactulose | 3.35 g/5 mL Oral SolutionAmber PET Bottle x 120 mL with HDPE screw cap and medicine cup (Box of 1's) | OTC | KCK Pharmaceutical Industries SDN.Malaysia | Greencore Pharma Inc. | DRP-13301 | Jan 20, 2028 | |
ZerriloseLactulose | 3.35g/5 mL SyrupPET Bottle with Pilfer Proof Cap x 60 mL and 120 mL (Box of 1's) | Rx | Opal Laboratories (Pvt.) LimitedPakistan | Kodapharm Med Corp.Importer: Accesspoint International Trading Inc. | DRP-4815-04 | Feb 10, 2027 | |
ZuloseLactulose | 3.33 g/5 mL Oral Solution | Rx | Magbro Healthcare Pvt. Ltd.India | Teramedix Pharma Trading Inc.Importer: Pharmakon Biotec Inc. | DRP-9124-02 | Sep 4, 2030 | |
(no brand name)Lactulose | 3.33 g/5 mL Syrup60 mL and 120 mL Amber-Colored PET Bottle (Box of 1's) | Rx | Global Pharmaceuticals (Pvt.) Ltd.Pakistan | Surestep Pharmaceuticals, Inc. | DR-XY49439 | Jul 2, 2030 |
Source: FDA Philippines product registration database. "Valid until" is the registration validity date listed by the FDA; a past date may mean a renewal is pending. Package insert links point to files published by the FDA.
Warnings/Precautions
Warnings and precautions (US label) US FDA label
WARNINGS A theoretical hazard may exist for patients being treated with lactulose who may be required to undergo electrocautery procedures during proctoscopy or colonoscopy. Accumulation of H 2 gas in significant concentration in the presence of an electrical spark may result in an explosive reaction. Although this complication has not been reported with lactulose, patients on lactulose therapy undergoing such procedures should have a thorough bowel cleansing with a non-fermentable solution.
Insufflation of CO 2 as an additional safeguard may be pursued but is considered to be a redundant measure.
Drug interactions
Drug interactions (US label) US FDA label
Drug Interactions Results of preliminary studies in humans and rats suggest that nonabsorbable antacids given concurrently with lactulose may inhibit the desired lactulose-induced drop in colonic pH. Therefore, a possible lack of desired effect of treatment should be taken into consideration before such drugs are given concomitantly with lactulose.
Adverse reactions
Adverse reactions (US label) US FDA label
ADVERSE REACTIONS Precise frequency data are not available. Initial dosing may produce flatulence and intestinal cramps, which are usually transient. Excessive dosage can lead to diarrhea with potential complications such as loss of fluids, hypokalemia, and hypernatremia. Nausea and vomiting have been reported.
Pregnancy considerations
Pregnancy (US label) US FDA label
Pregnancy Teratogenic Effects Reproduction studies have been performed in mice, rats, and rabbits at doses up to 3 or 6 times the usual human oral dose and have revealed no evidence of impaired fertility or harm to the fetus due to lactulose. There are, however, no adequate and well-controlled studies in pregnant women. Because animal reproduction studies are not always predictive of human response, this drug should be used during pregnancy only if clearly needed.
Breastfeeding considerations
Lactation (US label) US FDA label
Nursing Mothers It is not known whether this drug is excreted in human milk. Because many drugs are excreted in human milk, caution should be exercised when lactulose is administered to a nursing woman.
Pharmacokinetics
Urinary excretion has been determined to be 3% or less and is essentially complete within 24 hours.
Pharmacokinetics (US label) US FDA label
CLINICAL PHARMACOLOGY LACTULOSE is poorly absorbed from the gastro-intestinal tract and no enzyme capable of hydrolysis of this disaccharide is present in human gastrointestinal tissue. As a result, oral doses of lactulose reach the colon virtually unchanged. In the colon, lactulose is broken down primarily to lactic acid, and also to small amounts of formic and acetic acids, by the action of colonic bacteria, which results in an increase in osmotic pressure and slight acidification of the colonic contents.
This in turn causes an increase in stool water content and softens the stool. Since lactulose does not exert its effect until it reaches the colon, and since transit time through the colon may be slow, 24 to 48 hours may be required to produce desired bowel movement. Lactulose given orally to man and experimental animals resulted in only small amounts reaching the blood.
Urinary excretion has been determined to be 3% or less and is essentially complete within 24 hours.
Formulary and pricing (Philippines)
Government price references
| Preparation | Price (PHP) | Unit | Type |
|---|---|---|---|
| Lactulose 3.3 g/5 mL, 120 mL Syrup | ₱55.00–₱200.00Reference ₱92.50 | per unit | DPRI procurement range |
| Lactulose 3.35 g/5 mL, 120 mL Syrup | ₱65.00–₱108.33Reference ₱86.67 | per unit | DPRI procurement range |
Range = lowest-highest procurement price (highest usable only in GIDA areas); reference_price = 2021 DPRI ceiling (median)
These are government procurement and reimbursement references, not retail prices. Sources:
- DOH Drug Price Reference Index (DPRI) 2021, 9th edition (as of September 17, 2021); https://caro.doh.gov.ph/wp-content/uploads/2021/09/2021DPRI-as-of-9-17-2021.pdf, as of September 17, 2021
Formulary and coverage
| Philippine National Formulary | Listed as Lactulose |
| PNF listing | Oral: 3.3 g/5 mL (3.35 g/5 mL) syrup |
| PhilHealth GAMOT | No |
Sources:
- PNF Essential Medicines List, 8th ed. (as of November 2, 2022), DOH; https://www.philhealth.gov.ph/partners/providers/pdf/PNF-EML_11022022.pdf, as of November 2, 2022
Check availability
Prices and stock vary by branch; renalcarematters.com does not sell medicines or receive payment from pharmacies.
References
- U.S. Food and Drug Administration. Lactulose · Foxland Pharmaceuticals, Inc. [US FDA-approved label, version 10, October 15, 2026]. Via DailyMed/openFDA. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=3363bdbd-f0d1-45b3-8193-7fdb0a310cc2
- Food and Drug Administration Philippines. Verification portal (product registrations). https://verification.fda.gov.ph
- PNF Essential Medicines List, 8th ed. (as of November 2, 2022), DOH; https://www.philhealth.gov.ph/partners/providers/pdf/PNF-EML_11022022.pdf
- DOH Drug Price Reference Index (DPRI) 2021, 9th edition (as of September 17, 2021); https://caro.doh.gov.ph/wp-content/uploads/2021/09/2021DPRI-as-of-9-17-2021.pdf
This page shows official label and registry text only; no renalcarematters.com clinical summary has been approved for it yet.
Last updated: .